Swedbank Ab Astrazeneca PLC Transaction History
Swedbank Ab
- $86.1 Billion
- Q2 2025
A detailed history of Swedbank Ab transactions in Astrazeneca PLC stock. As of the latest transaction made, Swedbank Ab holds 4,077,554 shares of AZN stock, worth $307 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
4,077,554
Previous 3,375,775
20.79%
Holding current value
$307 Million
Previous $248 Million
14.84%
% of portfolio
0.33%
Previous 0.34%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,414Shares Held
499MCall Options Held
7.24MPut Options Held
2.65M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$3.91 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.59 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.37 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.35 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...